Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adlea in Acute Lateral Epicondylitis
NCT00130949Phase 2Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of capsaicin in Lateral Epicondylitis (LET) (2 arms), sponsored by AlgoRx Pharmaceuticals. Primary endpoint: Pain induced by resisted wrist dorsiflexion at 4 weeks. Started Nov 2004; status: completed.
02
Drugs
capsaicin
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT00130949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130949.